Title of article
Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study
Author/Authors
Timo Vesikari، نويسنده , , A Karvonen، نويسنده , , Roman Prymula، نويسنده , , V Schuster، نويسنده , , JC Tejedor، نويسنده , , R Cohen، نويسنده , , F Meurice، نويسنده , , HH Han، نويسنده , , S Damaso، نويسنده , , A Bouckenooghe، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2008
Pages
7
From page
1757
To page
1763
Abstract
Background
We aimed to assess the efficacy of the oral live attenuated human rotavirus vaccine Rotarix (RIX4414) for prevention of rotavirus gastroenteritis in European infants during their first 2 years of life.
Methods
3994 study participants were enrol
Journal title
The Lancet
Serial Year
2008
Journal title
The Lancet
Record number
592158
Link To Document